NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)
DUSA Technical Analysis
5
As on 31st Oct 2017 DUSA Share Price closed @ 22.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 19.07 & Strong Buy for SHORT-TERM with Stoploss of 21.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DUSA Share Price
Open | 22.58 | Change | Price | % |
High | 22.65 | 1 Day | 0.01 | 0.04 |
Low | 22.58 | 1 Week | 0.00 | 0.00 |
Close | 22.65 | 1 Month | 0.44 | 1.98 |
Volume | 23758 | 1 Year | 14.65 | 183.12 |
52 Week High 22.68 | 52 Week Low 19.79 |
NASDAQ USA Most Active Stocks
YHOO | 52.58 | 0.00% |
FNFG | 10.18 | -0.20% |
DELL | 13.86 | 0.22% |
RFMD | 16.59 | -2.07% |
MU | 44.31 | 6.39% |
RIMM | 13.03 | 0.39% |
BBEP | 0.12 | 0.00% |
GTAT | 0.44 | 0.00% |
SUSQ | 14.20 | -0.77% |
INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
DUSA Daily Charts |
DUSA Intraday Charts |
Whats New @ Bazaartrend |
DUSA Free Analysis |
|
DUSA Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 22.71 |
RESISTANCE | 22.69 |
SUPPORT | 22.61 |
SUPPORT | 22.59 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
DUSA Target for Month January
4th UP TARGET | 24 |
3rd UP TARGET | 23.57 |
2nd UP TARGET | 23.3 |
1st UP TARGET | 23.03 |
1st DOWN TARGET | 22.27 |
2nd DOWN TARGET | 22 |
3rd DOWN TARGET | 21.73 |
4th DOWN TARGET | 21.3 |
DUSA Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
DUSA Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
DUSA Pharmaceuticals, Inc. ( NASDAQ USA Symbol : DUSA )
Sector : Consumer Durables Major Pharmaceuticals And Other Stocks in Same Sector
Sector : Consumer Durables Major Pharmaceuticals And Other Stocks in Same Sector
DUSA Other Details
Segment | EQ | |
Market Capital | 155506272.00 | |
Sector | Consumer Durables Major Pharmaceuticals | |
Industry | ||
Offical website | > echo $website ; ?> |
DUSA Address
![]() |
N/A |
DUSA Latest News
DUSA Business Profile
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company�s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service